Vincent Medical Holdings Limited (HKG:1612)

Vincent Medical Holdings Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	96.3	104.38	69.17	57.28	-17.4	60.7
Depreciation & Amortization	39.74	34.8	36.14	38.33	40.76	38.79
Other Amortization	1.95	1.95	0.42	-	0.2	1.28
Loss (Gain) From Sale of Assets	-	-	-	-0.45	-0.62	2.26
Asset Writedown & Restructuring Costs	6.56	6.56	1.07	0.08	1.01	0.92
Loss (Gain) From Sale of Investments	-	-	1.15	1.66	3.82	10.73
Loss (Gain) on Equity Investments	-0.84	-0.84	0.33	-2.82	1.66	5.88
Stock-Based Compensation	0.4	0.4	0.94	1.88	2.94	1.07
Provision & Write-off of Bad Debts	-0.71	-0.71	2.61	1.09	-	3.29
Other Operating Activities	-89.42	15.86	6.03	7.59	35.91	12.94
Change in Accounts Receivable	-28.6	-28.6	-16.83	-13.01	8.01	-6.38
Change in Inventory	0.27	0.27	-3.71	-8.04	14.04	6.31
Change in Accounts Payable	18.24	18.24	-17.43	17.34	-22.78	-21.1
Change in Other Net Operating Assets	14.8	14.8	-6.42	24.05	8.21	2.38
Operating Cash Flow	58.69	167.12	73.48	124.98	75.76	119.05
Operating Cash Flow Growth	-29.31%	127.42%	-41.20%	64.95%	-36.36%	-42.79%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-85.37	-113.63	-94.47	-31.64	-18.6	-24.96
Sale of Property, Plant & Equipment	-	-	-	0.64	-	0.02
Divestitures	-	-	-	-	-	11.78
Sale (Purchase) of Intangibles	-5.99	-5.99	-5.54	-	-	-
Investment in Securities	-	-	-0	-0.01	-0.01	-7.75
Other Investing Activities	5.89	1.16	1.2	-31.36	0.51	0.38
Investing Cash Flow	-85.47	-118.46	-98.81	-62.37	-18.1	-20.52

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	111.42	90.35	21.06	26.5	42.46
Long-Term Debt Repaid	-	-62.03	-45.32	-55.04	-59.21	-61.4
Lease Payments	-13.75	-13.47	-14.48	-16.54	-16.61	-14.97
Net Debt Issued (Repaid)	48.04	49.39	45.03	-33.97	-32.71	-18.94
Issuance of Common Stock	5.41	4.57	-	-	0.21	4.65
Repurchase of Common Stock	-	-	-	-3.27	-2.65	-1.62
Common Dividends Paid	-32.4	-26.45	-19.94	-8.04	-16.35	-85.25
Other Financing Activities	-0.21	-0.17	1.3	-0.08	-	0.21
Financing Cash Flow	20.84	27.34	26.39	-45.37	-67.84	-100.95

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	1.54	1.44	-3.41	-0.8	-3.65	6.52
Net Cash Flow	-4.4	77.43	-2.34	16.44	-13.83	4.1

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	-26.68	53.48	-20.98	93.34	57.16	94.1
Free Cash Flow Growth	-	-	-	63.28%	-39.25%	-38.21%
Free Cash Flow Margin	-2.77%	5.73%	-2.62%	13.00%	9.09%	12.10%
Free Cash Flow Per Share	-0.04	0.08	-0.03	0.14	0.09	0.14
Levered Free Cash Flow	-16.98	51.8	-0.77	81.55	86.75	58.07
Unlevered Free Cash Flow	-15.18	52.36	0.08	82.6	88.54	59.59
Free Cash Flow After Leases	-40.42	40.01	-35.46	76.8	40.56	79.12

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	3.36	3.36	1.5	1.68	2.85	2.43
Cash Income Tax Paid	16.1	16.1	11.89	5.92	3.22	9.45
Change in Working Capital	4.72	4.72	-44.39	20.35	7.49	-18.78

Data Source: S&P Global Market Intelligence Last updated: Sep 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 12, 2026

Data Sources Report a data error